awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26853686-423E88DD-F188-4297-BD81-7F86F0EC6E20
Q26853686-423E88DD-F188-4297-BD81-7F86F0EC6E20
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26853686-423E88DD-F188-4297-BD81-7F86F0EC6E20
Targeting BCL2-Proteins for the Treatment of Solid Tumours
P2860
Q26853686-423E88DD-F188-4297-BD81-7F86F0EC6E20
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26853686-423E88DD-F188-4297-BD81-7F86F0EC6E20
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
37c62fb8806542db006f8cde35ec73995ce6c68e
P2860
A phase I trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-stage small cell lung cancer